Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PREGABALIN Cause Product use in unapproved indication? 2,553 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 2,553 reports of Product use in unapproved indication have been filed in association with PREGABALIN (Pregabalin). This represents 2.5% of all adverse event reports for PREGABALIN.

2,553
Reports of Product use in unapproved indication with PREGABALIN
2.5%
of all PREGABALIN reports
435
Deaths
820
Hospitalizations

How Dangerous Is Product use in unapproved indication From PREGABALIN?

Of the 2,553 reports, 435 (17.0%) resulted in death, 820 (32.1%) required hospitalization, and 437 (17.1%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PREGABALIN. However, 2,553 reports have been filed with the FAERS database.

What Other Side Effects Does PREGABALIN Cause?

Drug ineffective (13,664) Pain (12,996) Malaise (6,320) Dizziness (5,878) Off label use (5,713) Somnolence (5,528) Pain in extremity (5,023) Fatigue (4,909) Weight increased (4,903) Condition aggravated (4,901)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which PREGABALIN Alternatives Have Lower Product use in unapproved indication Risk?

PREGABALIN vs PREMARIN PREGABALIN vs PREMPRO PREGABALIN vs PRETOMANID PREGABALIN vs PREVISCAN PREGABALIN vs PREZISTA

Related Pages

PREGABALIN Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication PREGABALIN Demographics